Atlas Trials

Relapsed or Refractory Classical Hodgkin Lymphoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Classical Hodgkin Lymphoma

RecordFirmDate
Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT05216835)AstraZeneca2022-03-18
B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes (NCT03327571)Takeda2017-11-21

Track Relapsed or Refractory Classical Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.